GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (OTCPK:BMLKF) » Definitions » Cyclically Adjusted PB Ratio

BML (BMLKF) Cyclically Adjusted PB Ratio : 1.41 (As of May. 22, 2024)


View and export this data going back to 2009. Start your Free Trial

What is BML Cyclically Adjusted PB Ratio?

As of today (2024-05-22), BML's current share price is $12.675. BML's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $9.02. BML's Cyclically Adjusted PB Ratio for today is 1.41.

The historical rank and industry rank for BML's Cyclically Adjusted PB Ratio or its related term are showing as below:

BMLKF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.27   Med: 2.09   Max: 3.09
Current: 1.3

During the past years, BML's highest Cyclically Adjusted PB Ratio was 3.09. The lowest was 1.27. And the median was 2.09.

BMLKF's Cyclically Adjusted PB Ratio is ranked better than
64.66% of 133 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.98 vs BMLKF: 1.30

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BML's adjusted book value per share data for the three months ended in Dec. 2023 was $22.046. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $9.02 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


BML Cyclically Adjusted PB Ratio Historical Data

The historical data trend for BML's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BML Cyclically Adjusted PB Ratio Chart

BML Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.98 2.46 1.80 1.58 -

BML Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.58 1.44 1.35 1.41 -

Competitive Comparison of BML's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, BML's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BML's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BML's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BML's Cyclically Adjusted PB Ratio falls into.



BML Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BML's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=12.675/9.02
=1.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BML's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, BML's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=22.046/106.8000*106.8000
=22.046

Current CPI (Dec. 2023) = 106.8000.

BML Quarterly Data

Book Value per Share CPI Adj_Book
201403 12.720 95.700 14.195
201406 13.093 98.000 14.269
201409 12.639 98.500 13.704
201412 11.526 97.900 12.574
201503 11.601 97.900 12.656
201506 11.428 98.400 12.404
201509 12.017 98.500 13.030
201512 12.037 98.100 13.105
201603 12.976 97.900 14.156
201606 14.208 98.100 15.468
201609 15.073 98.000 16.426
201612 13.403 98.400 14.547
201703 14.036 98.100 15.281
201706 14.542 98.500 15.767
201709 14.986 98.800 16.199
201712 14.846 99.400 15.951
201803 16.078 99.200 17.310
201806 15.778 99.200 16.987
201809 15.831 99.900 16.924
201812 15.998 99.700 17.137
201903 16.294 99.700 17.454
201906 17.068 99.800 18.265
201909 17.570 100.100 18.746
201912 17.521 100.500 18.619
202003 17.413 100.300 18.541
202006 17.162 99.900 18.347
202009 18.297 99.900 19.561
202012 19.640 99.300 21.123
202103 20.012 99.900 21.394
202106 21.510 99.500 23.088
202109 23.483 100.100 25.055
202112 23.483 100.100 25.055
202203 24.542 101.100 25.926
202206 21.895 101.800 22.970
202209 21.951 103.100 22.739
202212 23.490 104.100 24.099
202303 23.485 104.400 24.025
202306 22.098 105.200 22.434
202309 21.416 106.200 21.537
202312 22.046 106.800 22.046

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BML  (OTCPK:BMLKF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BML Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of BML's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BML (BMLKF) Business Description

Traded in Other Exchanges
Address
5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.